https://www.selleckchem.com/products/ad-5584.html
05). It was determined that the development of AKI in normal-weight and overweight patients increased mortality ( 0.001) and that there was not a difference in mortality rates between obese patients with and without AKI. The risk of AKI development was higher in obese patients but not in those who were in serious conditions. Another paradox was that the development of AKI was associated with a higher mortality rate in normal-weight and overweight patients, but not in obese patients. Cerebrovascular diseases as a cause of admission
Like
Comment
Share
